Stanford EB Research Updates
Alfred T. Lane, MD, discusses EB research and treatment
The Butterfly Effect
- Gene Transfer Study for RDEB
- Characteristics of Dystrophic Epidermolysis Bullosa
- Epidermolysis Bullosa Clinical Research Consortium (EBCRC) Study
- NK-1 Receptor Antagonist for the Treatment of Itch in Epidermolysis Bullosa (EB) Patients
- A Phase 3 Study of SD-101 Cream in Patients with Epidermolysis Bullosa
- Autologous Fibroblast Study for RDEB
Support EB Research
Your support will help us accomplish our goal to ease the suffering of EB patients much sooner. To make a donation now, please click on the button below. If you wish to mail a donation, the addresses are listed below.
Stanford Department of Dermatology
Attn: Jean Tang, MD, PhD
450 Broadway Street
Pavilion C, 2nd Floor
Redwood City, CA 94063
tangy[at]stanford.edu
Stanford University School of Medicine
Att: Peter Marinkovich, MD
269 Campus Dr., Room 2145
Stanford CA 94305
mpm[at}stanford.edu
EB Medical Research Foundation
8909 W. Olympic Blvd., #22
Beverly Hills, CA 90211
EB Research Partnership
132 East 43rd Street, Suite 432
New York, NY 10017
info@ebresearch.org
(212) 554-1467